» Articles » PMID: 1653651

TrkC, a New Member of the Trk Family of Tyrosine Protein Kinases, is a Receptor for Neurotrophin-3

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1991 Sep 6
PMID 1653651
Citations 207
Authors
Affiliations
Soon will be listed here.
Abstract

We report the isolation and molecular characterization of trkC, a new member of the trk family of tyrosine protein kinase genes. trkC is preferentially expressed in the brain. In situ hybridization studies revealed trkC transcripts in the hippocampus, cerebral cortex, and the granular cell layer of the cerebellum. The product of the trkC gene has been identified as a glycoprotein of 145,000 daltons, gp145trkC, which is equally related to the previously characterized gp140trk and gp145trkB tyrosine kinases. gp145trkC is a functional receptor for neurotrophin-3 (NT-3). However, gp145trkC does not bind the highly related neurotrophic factors NGF or BDNF. In proliferating cells, the interaction between gp145trkC and NT-3 elicits a more efficient biological response than when NT-3 binds to its other receptors gp140trk and gp145trkB. These results indicate that gp145trkC may play an important role in mediating the neurotrophic effects of NT-3.

Citing Articles

Unraveling the AKT/ERK cascade and its role in Parkinson disease.

Keshri P, Singh S Arch Toxicol. 2024; 98(10):3169-3190.

PMID: 39136731 DOI: 10.1007/s00204-024-03829-9.


Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach.

M Al-Subaie A, Kamaraj B, Ahmad F, Alsamman K F1000Res. 2024; 12:345.

PMID: 39119195 PMC: 11307142. DOI: 10.12688/f1000research.131013.2.


Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib.

Xiang S, Lu X Acta Pharm Sin B. 2024; 14(2):517-532.

PMID: 38322338 PMC: 10840435. DOI: 10.1016/j.apsb.2023.11.010.


Neurotrophin-3 promotes peripheral nerve regeneration by maintaining a repair state of Schwann cells after chronic denervation via the TrkC/ERK/c-Jun pathway.

Xu X, Song L, Li Y, Guo J, Huang S, Du S J Transl Med. 2023; 21(1):733.

PMID: 37848983 PMC: 10583391. DOI: 10.1186/s12967-023-04609-2.


Phase separation underlies signaling activation of oncogenic NTRK fusions.

Zhu T, Xie J, He H, Li H, Tang X, Wang S Proc Natl Acad Sci U S A. 2023; 120(42):e2219589120.

PMID: 37812694 PMC: 10589674. DOI: 10.1073/pnas.2219589120.